Target Price | $79.56 |
Price | $68.46 |
Potential | 16.21% |
Number of Estimates | 36 |
36 Analysts have issued a price target Nike 2026 . The average Nike target price is $79.56. This is 16.21% higher than the current stock price. The highest price target is $126.00 84.05% , the lowest is $38.38 43.94% . | |
A rating was issued by 43 analysts: 23 Analysts recommend Nike to buy, 18 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Nike stock has an average upside potential 2026 of 16.21% . Most analysts recommend the Nike stock at Purchase. |
39 Analysts have issued a sales forecast Nike 2026 . The average Nike sales estimate is $47.1b . This is 1.51% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $49.9b 7.44% , the lowest is $44.6b 4.02% .
This results in the following potential growth metrics:
2025 | $46.3b | 9.84% |
---|---|---|
2026 | $47.1b | 1.80% |
2027 | $49.6b | 5.22% |
2028 | $52.1b | 5.00% |
2029 | $55.8b | 7.18% |
2030 | $58.9b | 5.59% |
2031 | $62.4b | 5.93% |
2032 | $66.1b | 5.92% |
32 Analysts have issued an Nike EBITDA forecast 2026. The average Nike EBITDA estimate is $3.7b . This is 12.03% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.6b 9.01% , the lowest is $2.9b 31.69% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $4.5b | 40.14% |
---|---|---|
2026 | $3.7b | 18.14% |
2027 | $4.9b | 33.64% |
2028 | $6.1b | 24.26% |
2029 | $8.2b | 33.19% |
2030 | $9.0b | 9.99% |
2031 | $10.5b | 17.19% |
2032 | $11.5b | 9.33% |
2025 | 9.74% | 33.61% |
---|---|---|
2026 | 7.83% | 19.60% |
2027 | 9.95% | 27.08% |
2028 | 11.77% | 18.29% |
2029 | 14.63% | 24.30% |
2030 | 15.24% | 4.17% |
2031 | 16.86% | 10.63% |
2032 | 17.40% | 3.20% |
38 Nike Analysts have issued a net profit forecast 2026. The average Nike net profit estimate is $2.5b . This is 14.39% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.4b 18.39% , the lowest is $1.9b 35.50% .
This results in the following potential growth metrics and future Net Margins:
2025 | $3.2b | 43.53% |
---|---|---|
2026 | $2.5b | 23.01% |
2027 | $3.7b | 47.80% |
2028 | $4.5b | 24.03% |
2029 | $5.8b | 27.73% |
2030 | $7.0b | 20.57% |
2031 | $8.5b | 21.11% |
2032 | $9.4b | 11.44% |
2025 | 6.95% | 37.36% |
---|---|---|
2026 | 5.26% | 24.33% |
2027 | 7.38% | 40.30% |
2028 | 8.72% | 18.16% |
2029 | 10.40% | 19.27% |
2030 | 11.87% | 14.13% |
2031 | 13.57% | 14.32% |
2032 | 14.28% | 5.23% |
38 Analysts have issued a Nike forecast for earnings per share. The average Nike EPS is $1.68 . This is 13.85% lower than earnings per share in the financial year 2025. The highest EPS forecast is $2.32 18.97% , the lowest is $1.26 35.38% .
This results in the following potential growth metrics and future valuations:
2025 | $2.16 | 42.09% |
---|---|---|
2026 | $1.68 | 22.22% |
2027 | $2.48 | 47.62% |
2028 | $3.08 | 24.19% |
2029 | $3.93 | 27.60% |
2030 | $4.74 | 20.61% |
2031 | $5.74 | 21.10% |
2032 | $6.39 | 11.32% |
Current | 35.11 | 50.43% |
---|---|---|
2026 | 40.80 | 16.21% |
2027 | 27.61 | 32.33% |
2028 | 22.26 | 19.38% |
2029 | 17.42 | 21.74% |
2030 | 14.45 | 17.05% |
2031 | 11.93 | 17.44% |
2032 | 10.71 | 10.23% |
Based on analysts' sales estimates for 2026, the Nike stock is valued at an EV/Sales of 2.13 and an P/S ratio of 2.15 .
This results in the following potential growth metrics and future valuations:
Current | 2.17 | 10.33% |
---|---|---|
2026 | 2.13 | 1.64% |
2027 | 2.03 | 4.96% |
2028 | 1.93 | 4.76% |
2029 | 1.80 | 6.70% |
2030 | 1.71 | 5.30% |
2031 | 1.61 | 5.59% |
2032 | 1.52 | 5.59% |
Current | 2.18 | 10.88% |
---|---|---|
2026 | 2.15 | 1.49% |
2027 | 2.04 | 4.96% |
2028 | 1.94 | 4.76% |
2029 | 1.81 | 6.70% |
2030 | 1.72 | 5.30% |
2031 | 1.62 | 5.60% |
2032 | 1.53 | 5.59% |
Analyst | Rating | Action | Date |
---|---|---|---|
Keybanc |
Sector Weight
➜
Overweight
|
Upgrade | Oct 02 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 01 2025 |
Stifel |
Hold
➜
Hold
|
Unchanged | Oct 01 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 01 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Oct 01 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Oct 01 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 01 2025 |
Analyst Rating | Date |
---|---|
Upgrade
Keybanc:
Sector Weight
➜
Overweight
|
Oct 02 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 01 2025 |
Unchanged
Stifel:
Hold
➜
Hold
|
Oct 01 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 01 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Oct 01 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Oct 01 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 01 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.